glucagon has been researched along with Adenoma, alpha-Cell in 161 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 62 (38.51) | 18.7374 |
1990's | 53 (32.92) | 18.2507 |
2000's | 24 (14.91) | 29.6817 |
2010's | 20 (12.42) | 24.3611 |
2020's | 2 (1.24) | 2.80 |
Authors | Studies |
---|---|
Deng, Y; Dong, S; Han, L; Jiang, Y; Li, E; Li, W; Ma, Q; Ma, Z; Ren, J; Wang, Z; Wu, Y; Wu, Z; Xu, G; Yang, X | 1 |
Boujan, N; Géraud, C | 1 |
Carilli, A; Pellini Ferreira, B; Vasquez, J | 1 |
Feldmann, R; Steiner, A; Wahl, S | 1 |
Jang, YH; Lee, HJ | 1 |
Hyo, T; Imamura, M; Kawai, J; Komoto, I; Kurose, T; Kuwata, H; Miura, Y; Nagamatsu, T; Rokutan, M; Seino, Y; Shimizu, S; Usui, R; Watanabe, K; Yabe, D | 1 |
Bai, JG; Ma, QY; Wu, SL; Wu, Z; Xu, J | 1 |
Cao, Y; Cheng, Y; Gu, Y; Jiang, X; Li, F; Li, Y; Lu, J; Ning, G; Peng, Y; Su, Y; Wang, W; Zhang, C | 1 |
An, J; Chen, X; Huo, J; Liu, P; Ren, J; Wu, J | 1 |
Challis, BG; Damjanov, I; Holst, JJ; Wewer Albrechtsen, NJ | 1 |
Holst, JJ; Knop, FK; Kuhre, RE; Pedersen, J; Wewer Albrechtsen, NJ | 1 |
Althoff, K; Beisser, D; Cario, E; De Preter, K; Elges, S; Eyking, A; Fielitz, K; Hartmann, W; Klein-Hitpass, L; Klöppel, G; Knösel, T; Nonnekens, J; Ohli, J; Reis, H; Schramm, A; Schüller, U; Schulte, JH; Schulte, M | 1 |
Holst, JJ; Knop, FK; Pedersen, J; Wewer Albrechtsen, NJ | 1 |
Gin, VC; Zacharias, M | 1 |
Aozasa, K; Funahashi, T; Hayashi, I; Iwahashi, H; Kato, K; Katsube, F; Kim, T; Kizu, T; Matsuhisa, M; Miyagawa, J; Nakamori, S; Nammo, T; Okauchi, Y; Okita, K; Osuga, K; Shimomura, I; Tamaki, Y; Uno, S; Yamagata, K | 1 |
McGevna, L; Tavakkol, Z | 1 |
Bertolino, P; Bonnavion, R; Calender, A; Carreira, C; Herrera, PL; Lu, J; Seigne, C; Zhang, CX | 1 |
Amaral, C; Carvalho, A; Carvalho, R; Lobo, I; Machado, S | 1 |
Batcher, E; Gianoukakis, AG; Madaj, P | 1 |
Cuenca Cuenca, JI; Guerrero Vázquez, R; Navarro González, E; Oliva Rodríguez, R; Sánchez Alberdi, F | 1 |
Harsing, J; Karpati, S; Kovacs, J; Marschalko, M; Otto, AI; Toth, M; Tulassay, Z; Zalatnai, A | 1 |
Deguchi, H; Ichinose, M; Iguchi, M; Inoue, I; Iso-O, N; Kato, J; Kawai, M; Maeda, H; Maekita, T; Moribata, K; Nakamura, Y; Oka, M; Shingaki, N; Shirai, K; Tamai, H; Ueda, K; Yamaue, H; Yanaoka, K; Yasuoka, H | 1 |
Abe, M; Azemoto, N; Furukawa, S; Hiasa, Y; Ikeda, Y; Koizumi, M; Kumagi, T; Kuroda, T; Kushihata, F; Matsuura, B; Onji, M; Soga, Y; Watanabe, J; Yamanishi, H; Yokota, T | 1 |
Isogawa, A; Kishi, S; Mori, M; Sakamoto, K; Shiba, T | 1 |
De Delas, JS; Echenique-Elizondo, M; Elorza, JL | 1 |
Folny, V; Lukovic, L; Pascal, M; Pouzet, B; Raufaste, D; Rochard, P; Serradeil-Le Gal, C | 1 |
Tomita, T | 1 |
Bayle, P; Bazex, J; Bennet, A; Danjoux, M; Lalande, T; Marguery, MC; Marty, C | 1 |
Bassi, C; Gumbs, AA; Parisi, V; Sargenti, M | 1 |
Echenique-Elizondo, M; Elorza Orúe, JL; Ibáñez Aguirre, J; Martinez de Lizarduy, I; Tuneu Valls, A | 1 |
Avila-Funes, A; García-de-Acevedo, B; Orozco-Topete, R; Remes-Troche, JM; Zuñiga-Varga, J | 1 |
Badger, J; Tierney, EP | 1 |
Chen, J; Ostenson, CG | 1 |
Ito, T; Kawabe, K | 1 |
Couvelard, A; Fregeville, A; Paradis, V; Vilgrain, V; Warshauer, DM | 1 |
Eigentler, TK; Mueller-Horvart, C; Overkamp, D; Raab, HR; Radny, P; Rassner, G; Soennichsen, K; Sotlar, K; Viebahn, R | 1 |
Appetecchia, M; Carducci, M; Carpanese, L; Ferretti, E; Izzo, F; Marandino, F; Terzoli, E | 1 |
Hamaguchi, T; Konya, H; Miyagawa, J; Namba, M | 1 |
Dunder, K; Eriksson, B; Granberg, D; Janson, ET; Kindmark, H; Oberg, K; Skogseid, B; Sundin, A; Welin, S | 1 |
Asai, Y; Hai, S; Ichikawa, T; Kodai, S; Kubo, S; Shinkawa, H; Takemura, S; Tanaka, H; Wakasa, K; Yamamoto, S | 1 |
Chaw, L; Hood, AF; Krop, TM | 1 |
Horiuchi, T; Nakamura, K; Shimizu, N; Tanaka, K; Watabe, T; Yoshida, H | 1 |
Acott, KM; Mueggler, PA; Parker, F; Peterson, LL; Shaw, JC | 1 |
Martin, JK; Rader, DL; Scheithauer, BW | 1 |
Wilkinson, DS | 1 |
Pascal, JP; Pradayrol, L; Pradére, B; Vinel, JP; Voigt, JJ | 1 |
Lefebvre, PJ; Luyckx, AS | 1 |
Fujimori, K; Hayashi, H; Inamori, S; Mizumoto, R; Yamamoto, N; Yano, T | 1 |
Hendriks, T; Jansen, JB; van Tongeren, JH | 1 |
Stacpoole, PW | 1 |
Badrinath, K; Banerji, M; Dorsch, TR; Lawrence, AM; Prinz, RA; Sparagana, M | 1 |
Arao, AT; Kitoh, M; Ohyama, K | 1 |
Fukushima, H; Kitoh, M; Konno, T; Takemiya, M; Uzawa, H; Yamaguchi, K | 1 |
Gorguet, B; Hollande, E; Pradayrol, L; Vinel, JP; Voigt, JJ | 1 |
Alford, FP; Larkins, R; Nankervis, A; Ng, KW; Proietto, J | 1 |
Fukushima, H; Kitoh, M; Konno, T; Miyayama, H; Takemiya, M; Takeuchi, T; Takeya, M | 1 |
Montenegro-Rodas, F; Samaan, NA | 1 |
Ditty, JF; Lang, PG | 1 |
Fankhauser, S; Heitz, PU; Keller, U; Schumacher, A; Trimble, ER | 1 |
Shimizu, N; Yoshida, H | 1 |
Dalle-Furnari, MA; Garraud, JC; Lefebvre, J; Lelièvre, G; Linquette, M; Luyckx, A; Mazzuca, M; Proye, C | 1 |
Ikeuchi, T; Inoue, S; Numakawa, T; Suda, T; Sugimasa, T; Takamura, Y | 1 |
Block, M; Bloom, SR; Hafez, GR; Lloyd, RV; Mack, E; Warner, TF | 1 |
Holst, JJ | 1 |
Bloom, SR; Polak, JM; Wood, SM | 1 |
Abraira, C; DeBartolo, M; Katzen, R; Lawrence, AM | 1 |
Ho, PW; Hoge, AF; Moore, GW | 1 |
Kajikawa, K; Katsuda, S; Konishi, K; Miwa, K; Nakanishi, I; Yonemura, Y | 1 |
Buchanan, KD; Flanagan, RW; O'Gorman, D; Stevens, FM | 1 |
von Schenck, H | 1 |
Farmer, KL | 1 |
Fehmann, HC; Göke, B; Lankat-Buttgereit, B; Strowski, M | 1 |
Blume, N; Holst, JJ; Jensen, HI; Karlsen, C; Larsson, LI; Madsen, OD | 1 |
Lam, KS; Lam, KY; Wat, MS | 1 |
Fehmann, HC; Gherzi, R; Göke, B; Ponassi, M; Volz, A | 1 |
Engemann, R; Marx, A; Meyer, D; Thiede, A | 1 |
Funakoshi, A; Iwamoto, N; Matsuoka, Y; Shima, K; Tateishi, K; Yasunami, Y | 1 |
Fehmann, HC; Göke, B; Strowski, M | 1 |
Funakoshi, A; Ikeda, S; Jimi, A; Ryu, S; Shinozaki, H; Yasunami, Y | 1 |
Kawakita, N; Nagahata, Y; Saitoh, Y; Urakawa, T; Wada, T; Yamamoto, M; Yoshizumi, K | 1 |
Böcker, W; Brink, M; Fischer-Colbrie, R; Freytag, G; Heitz, PU; Kirchmair, R; Klöppel, G; Schmid, KW | 1 |
Briata, P; Fehmann, HC; Gherzi, R; Göke, B | 1 |
Jockenhövel, F; Krenning, EP; Lamberts, SW; Lederbogen, S; Olbricht, T; Reinwein, D; Schmidt-Gayk, H | 1 |
Buettger, C; Epstein, AJ; Hang, TL; Matschinsky, FM; Ronner, P | 1 |
Fujikawa, J; Imamura, M; Imura, H; Inoue, K; Kadowaki, S; Kojima, H; Seino, Y; Yamamoto, T | 1 |
Henry, JG; Inzucchi, SE; Kinder, BK; Xue, N | 1 |
Bouwens, L; De Vos, A; Heimberg, H; Madsen, O; Moens, K; Pipeleers, D; Quartier, E; Schuit, F; Van Schaftingen, E | 1 |
Thompson, JC; Townsend, CM | 1 |
Asa, SL; Brubaker, PL; Drucker, DJ; Erlich, P | 1 |
Andersen, FG; Blume, N; Holst, JJ; Jensen, J; Jørgensen, MC; Madsen, OD; Serup, P | 1 |
O'Dorisio, TM; Thompson, CS; Woltering, EA | 1 |
Fatourechi, V; Kvols, LK; Wermers, RA | 1 |
Strohm, WD | 1 |
Jensen, CH; Larsson, LI; Teisner, B; Tornehave, D | 1 |
Ishizuka, T; Itakura, M; Kamura, M; Okumura, S; Saji, S; Sarui, H; Shimokawa, K; Takao, H; Takuno, H; Yasuda, K; Yoshimoto, K | 1 |
Boulat, O; Chapuis, G; Chaubert, P; Gomez, F; Haefliger, JA; Nicod, P; Temler, E; Waeber, G | 1 |
Blume, N; Holst, JJ; Jensen, HI; Jensen, PB; Larsen, PJ; Madsen, OD; Mikkelsen, JD | 1 |
Totsuka, Y | 2 |
Cohen, PR; Mullans, EA | 1 |
Galehshahi, FS; Göke, B; Lankat-Buttgereit, B | 1 |
Hsu, WH; Yibchok-anun, S | 1 |
Bode, HP; Fehmann, HC; Göke, B; Weber, S | 1 |
Dandrifosse, AC; Dandrifosse, G; Dandrifosse, JF; Piérard, G; Scheen, AJ | 1 |
Davies, MG; Kingsnorth, AN; Nightingale, KJ | 1 |
Barazzoni, R; Tessari, P; Tiengo, A; Zanetti, M | 1 |
Aichelmann, E; Dienes, HP; Hölscher, AH; Neuhaus, H; Wickenhauser, C | 1 |
Allenspach, K; Arnold, P; Eberle, C; Glaus, T; Hauser, B; Komminoth, P; Wolff, C | 1 |
Dietze, O; Hacker, GW; Hauser-Kronberger, C; Sattlegger, P; Sungler, P; Weitgasser, R | 1 |
Chastain, MA | 1 |
Abu-Basha, EA; Cheng, H; Ding, J; Hsu, WH; Ioudina, M; Yibchok-anun, S | 1 |
Chan, JC; Chung, SC; Cockram, CS; Leung, CB; Yeung, VT | 1 |
Baba, H; Jahoor, F; Klein, S; Shepherd, M; Townsend, CM; Wolfe, RR | 1 |
Bloom, SR; Efrat, S; Ghatei, MA; Polak, JM; Rindi, G; Solcia, E | 1 |
Bani, D; Biliotti, G; Sacchi, TB | 1 |
Raimer, SS; Shepherd, ME; Smith, EB; Tyring, SK | 1 |
Betsholtz, C; Madsen, OD; Michelsen, B; Nielsen, JH; Nishi, M; Steiner, DF; Westermark, P | 1 |
Beuers, U; Permanetter, W; Richter, WO; Ritter, MM; Schraudolph, M; Schwandt, P | 1 |
Alarcón, C; Bataille, D; Kervran, A; Valverde, I | 1 |
Green, MD; Holmes, A; Kilpatrick, C; Proietto, J | 1 |
Asa, SL; Brubaker, PL; Drucker, DJ; Silverberg, J | 1 |
Kono, N; Kuwajima, M; Namba, M; Tarui, S; Watanabe, N | 1 |
Abell, E; Hunt, SJ; Narus, VT | 1 |
Efrat, S; Habener, JF; Hanahan, D; Mojsov, S; Powers, AC; Spector, D | 1 |
Ahlman, H; Ahlund, L; Dahlström, A; Grimelius, L; Theodorsson, E | 1 |
Cho, K; Moattari, AR; Vinik, AI | 1 |
Doi, K; Morita, S | 1 |
Edney, JA; Hofmann, S; Kessinger, A; Thompson, JS | 1 |
Varas Lorenzo, MV | 1 |
Bani Sacchi, T; Bani, D; Biliotti, G | 1 |
Bazex, J; Gouzi, JL; Marguery, MC; Pradere, B | 1 |
Sato, J | 1 |
Diebold, MD; Mathis, P; Servel, R | 1 |
Blanc, D; Gillet, M; Laurent, R; Quencez, E; Zultak, M | 1 |
Forbes, A; Lee, SM; Williams, R | 1 |
Hashizume, T; Kano, T; Kiryu, H; Nakano, R; Noda, K | 1 |
Bloom, SR; Williams, SJ; Wynick, D | 1 |
Amblard, P; Béani, JC; Benhamou, PY; Boizel, R; Reymond, JL | 1 |
Carbillet, JP; Gillet, M; Landecy, G; Laurent, R; Mantion, G; Nguyen, N; Quencez, E; Rodier, C | 1 |
Gray, C; Ratcliffe, JG; Roberts, I; Tan, K; White, A | 1 |
Fujita, J; Horio, T; Imamura, S; Ishida, H; Matsukura, S; Naito, A; Seino, Y; Takahashi, K; Taminato, T; Tobe, T | 1 |
Boden, G; Eisenschmid, BL; Owen, OE; Ryan, IG; Shelmet, JJ | 1 |
Charleux, H; Olivier, A; Orsoni, JL; Passa, P; Penchet, A | 1 |
Altimari, AF; Bhoopalam, N; Lange, CL; O'Dorsio, T; Prinz, RA; Sandberg, L | 1 |
Dueno, MI; Krejs, GJ; Orci, L; Popma, JJ; Santangelo, WC; Unger, RH | 1 |
Bloom, SR; Polak, JM | 1 |
Comi, R; Drucker, DJ; Habener, JF; Mojsov, S; Philippe, J; Powers, AC | 1 |
Egawa, K; Fujise, K; Hihara, M; Joh, K; Kawase, H; Kitahara, T; Matsuura, T; Nakagawa, J; Nakahara, M; Ohara, K | 1 |
Catling, SJ; Nicoll, JM | 1 |
Farmer, ER; Skouge, JW | 1 |
Kändler, C; Kohnert, KD; Woltanski, KP; Ziegler, M | 1 |
Kaimori, M; Kikuchi, Y; Kitazima, S; Matsumoto, J; Nakamura, K; Noto, N; Ohto, T; Sasaki, G | 1 |
Blázquez, E; Torre, L; Vazquez, JA | 1 |
Khandekar, JD; Sriratana, P | 1 |
Bishop, AE; Bloom, SR; Hamid, QA; Polak, JM; Sikri, KL; Varndell, IM | 1 |
Hanaguri, K; Hasegawa, M; Hirota, S; Kadowaki, S; Ohtsuki, S; Sako, M; Shimizu, T; Yamamoto, M | 1 |
Grizzle, WE; Herrera, GA; Kheir, SM; Lee, I; Omura, EF | 1 |
Nimura, Y; Ohtsuka, K; Shionoya, S; Takaesu, H; Yasui, K; Yokoi, S | 1 |
Chorzelski, T; Jankowski, M; Kabala, A; Karnafel, W; Lawecki, J; Piniewska-Hułas, D; Switka, S; Szymerska, E | 1 |
Gould, VE; Staren, ED; Steinecker, GA | 1 |
Franchimont, C; Gerard, J; Lapiere, CM; Luyckx, AS; Pierard, GE | 1 |
17 review(s) available for glucagon and Adenoma, alpha-Cell
Article | Year |
---|---|
Do glucagonomas always produce glucagon?
Topics: Animals; Gastrointestinal Diseases; Gene Expression Regulation; Glicentin; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Glucagonoma; Humans; Hypoglycemia; Islets of Langerhans; Oxyntomodulin; Pancreas; Pancreatic Neoplasms; Peptide Fragments; Peptides; Phenotype; Proglucagon; Protein Domains | 2016 |
The biology of glucagon and the consequences of hyperglucagonemia.
Topics: Diabetes Mellitus; Glucagon; Glucagon-Like Peptide 1; Glucagonoma; Humans; Liver; Neoplasms; Non-alcoholic Fatty Liver Disease; Oxyntomodulin; Pancreas; Receptors, Glucagon | 2016 |
Pancreatic neuroendocrine tumors.
Topics: Gastrinoma; Gastrins; Glucagon; Glucagonoma; Hormones; Humans; Hypoglycemia; Insulinoma; Neuroendocrine Tumors; Pancreatic Neoplasms; Somatostatinoma; Vasoactive Intestinal Peptide; Vipoma | 2011 |
Etiology and pathogenesis of necrolytic migratory erythema: review of the literature.
Topics: Erythema; Glucagon; Glucagonoma; Humans; Inflammation Mediators; Liver Diseases; Nutrition Disorders; Pancreatic Neoplasms | 2004 |
[Pancreatic glucagon (IRG), enteroglucagon (EG)].
Topics: Biomarkers; Diabetes Mellitus; Diagnostic Techniques, Endocrine; Dumping Syndrome; Glucagon; Glucagon-Like Peptides; Glucagonoma; Humans; Liver Diseases; Pancreatic Diseases; Pancreatic Neoplasms; Radioimmunoassay; Reference Values; Specimen Handling | 2005 |
[Glucagonoma].
Topics: Biomarkers; Diagnosis, Differential; Diagnostic Imaging; Diagnostic Techniques, Endocrine; Glucagon; Glucagonoma; Humans; Mutation; Pancreatic Neoplasms; Prognosis; Proto-Oncogene Proteins; Von Hippel-Lindau Tumor Suppressor Protein | 2006 |
[The glucagonomas (author's transl)].
Topics: Adenoma, Islet Cell; Adult; Aged; Amino Acids; Anemia; Arginine; Body Weight; Cholesterol; Dacarbazine; Diabetes Mellitus; Diagnosis, Differential; Erythema; Female; Glossitis; Glucagon; Glucagonoma; Humans; Hypoproteinemia; Male; Middle Aged; Nervous System Diseases; Pancreatic Neoplasms; Somatostatin; Streptozocin; Thrombophlebitis; Zinc | 1981 |
The glucagonoma syndrome: clinical features, diagnosis, and treatment.
Topics: Adenoma, Islet Cell; Adult; Amino Acids; Diagnosis, Differential; Female; Glucagon; Glucagonoma; Humans; Hyperglycemia; Insulinoma; Male; Middle Aged; Pancreatic Neoplasms; Paraneoplastic Endocrine Syndromes; Skin | 1981 |
Glucagonoma tumors and syndrome.
Topics: Adenoma, Islet Cell; Adolescent; Adult; Aged; Child; Diagnosis, Differential; Erythema; Female; Glucagon; Glucagonoma; Glucose Tolerance Test; Humans; Male; Middle Aged; Necrosis; Pancreatic Diseases; Pancreatic Neoplasms; Prognosis; Skin; Streptozocin; Syndrome | 1981 |
Gut hormone secreting tumours.
Topics: Adenoma, Islet Cell; Bombesin; Bronchial Neoplasms; C-Peptide; Carcinoma, Small Cell; Diagnosis, Differential; Endocrine System Diseases; Erythema; Gastrointestinal Hormones; Glucagon; Glucagonoma; Humans; Insulin; Insulin Secretion; Insulinoma; Male; Neoplasms; Neurotensin; Pancreatic Hormones; Pancreatic Neoplasms; Pancreatic Polypeptide; Somatostatinoma; Vasoactive Intestinal Peptide; Zollinger-Ellison Syndrome | 1983 |
Additional tests of interest to the dermatologist.
Topics: alpha 1-Antitrypsin Deficiency; Angioedema; Complement C1 Inactivator Proteins; Erythema; Glucagon; Glucagonoma; Histamine; Humans; Hydroxyindoleacetic Acid; Malignant Carcinoid Syndrome; Mastocytosis; Pancreatic Neoplasms; Panniculitis; Peptidyl-Dipeptidase A; Sarcoidosis; Skin Diseases; Syndrome | 1994 |
The clinical use of gastrointestinal hormones for alimentary tract disease.
Topics: Adenoma, Islet Cell; Cholecystokinin; Digestive System Diseases; Gastrointestinal Hormones; Glucagon; Glucagonoma; Humans; Multiple Endocrine Neoplasia Type 1; Pancreatic Neoplasms; Pancreatic Polypeptide; Somatostatin; Somatostatinoma; Vipoma; Zollinger-Ellison Syndrome | 1996 |
[Glucagonoma and somatostatinoma].
Topics: Glucagon; Glucagonoma; Glucose; Humans; Insulin; Insulin Secretion; Insulinoma; Pancreatic Neoplasms; Somatostatinoma | 1998 |
Iatrogenic necrolytic migratory erythema: a case report and review of nonglucagonoma-associated necrolytic migratory erythema.
Topics: Adult; Diagnosis, Differential; Erythema; Female; Gastrointestinal Agents; Glucagon; Glucagonoma; Hemangiopericytoma; Humans; Hypoglycemia; Iatrogenic Disease; Insulin-Like Growth Factor II; Kidney Neoplasms; Liver Neoplasms; Necrosis; Pancreatic Neoplasms; Paraneoplastic Syndromes; Skin Diseases, Vesiculobullous | 1998 |
The glucagonoma syndrome: a review of its features and discussion of new perspectives.
Topics: Amino Acid Sequence; Antineoplastic Agents, Hormonal; Fatty Acids; Glucagon; Glucagonoma; Humans; Liver Diseases; Molecular Sequence Data; Octreotide; Pancreatic Neoplasms; Zinc | 2001 |
[Pancreatic tumor with diabetes and necrotic migratory erythema. Glucagonoma or proglucagonoma?].
Topics: Adenoma, Islet Cell; Adult; Dermatitis, Exfoliative; Diabetes Mellitus; Female; Glucagon; Glucagonoma; Humans; Pancreatic Neoplasms; Proglucagon; Protein Precursors | 1988 |
Glucagonoma syndrome.
Topics: Adenoma, Islet Cell; Erythema; Female; Glucagon; Glucagonoma; Humans; Male; Middle Aged; Octreotide; Pancreatic Neoplasms; Somatostatin; Syndrome | 1987 |
1 trial(s) available for glucagon and Adenoma, alpha-Cell
Article | Year |
---|---|
Calcium reverses octreotide inhibition of insulin and glucagon levels in patients with insulinoma and glucagonoma.
Topics: Antineoplastic Agents, Hormonal; Calcium; Glucagon; Glucagonoma; Humans; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Insulinoma; Octreotide; Pancreatic Neoplasms; Secretin; Tolbutamide | 1996 |
143 other study(ies) available for glucagon and Adenoma, alpha-Cell
Article | Year |
---|---|
Necrolytic migratory erythema is an important visual cutaneous clue of glucagonoma.
Topics: Adult; Diabetes Mellitus; Female; Glucagon; Glucagonoma; Humans; Male; Middle Aged; Necrolytic Migratory Erythema; Pancreatic Neoplasms; Somatostatin; Young Adult | 2022 |
Neuropsychiatric symptoms, skin disease, and weight loss: necrolytic migratory erythema and a glucagonoma.
Topics: Glucagon; Glucagonoma; Humans; Male; Middle Aged; Necrolytic Migratory Erythema; Neoplasm Invasiveness; Neoplasm Staging; Pancreatectomy; Pancreatic Neoplasms; Rare Diseases; Recovery of Function; Risk Assessment; Syndrome; Treatment Outcome; Weight Loss | 2020 |
Metastatic Hepatoid Carcinoma of the Pancreas: First Description of Treatment With Capecitabine and Temozolomide.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Biopsy; Capecitabine; Carcinoma, Hepatocellular; Dacarbazine; Glucagon; Glucagonoma; Humans; Jaundice; Liver; Male; Neoplasm Metastasis; Pancreatic Neoplasms; Prognosis; Temozolomide; Treatment Outcome | 2017 |
Normoglycemic glucagonoma syndrome associated with necrolytic migratory erythema.
Topics: Adult; Blood Glucose; Glucagon; Glucagonoma; Glycated Hemoglobin; Humans; Male; Necrolytic Migratory Erythema; Pancreatic Neoplasms | 2018 |
Necrolytic migratory erythema.
Topics: Aged; Glucagon; Glucagonoma; Humans; Male; Necrolytic Migratory Erythema; Pancreatic Neoplasms; Tomography, X-Ray Computed | 2019 |
Enhanced glucagon-like peptide-1 secretion in a patient with glucagonoma: implications for glucagon-like peptide-1 secretion from pancreatic α cells in vivo.
Topics: Adult; Arteries; Calcium Gluconate; Food; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Glucagonoma; Humans; Injections, Intra-Arterial; Male; Middle Aged; Multiple Endocrine Neoplasia Type 1; Pancreatectomy | 2013 |
Necrolytic migratory erythema as the first manifestation of pancreatic neuroendocrine tumor.
Topics: Adult; Female; Glucagon; Glucagonoma; Humans; Necrolytic Migratory Erythema; Neuroendocrine Tumors; Pancreatic Neoplasms; Prognosis | 2014 |
Conditional deletion of Men1 in the pancreatic β-cell leads to glucagon-expressing tumor development.
Topics: Animals; Female; Gene Deletion; Gene Expression Regulation, Neoplastic; Genotype; Glucagon; Glucagon-Secreting Cells; Glucagonoma; Insulin-Secreting Cells; Male; Mice; Mice, Knockout; Pancreatic Neoplasms; Proto-Oncogene Proteins; Transcription Factors | 2015 |
Delayed diagnosis of glucagonoma syndrome: a case report.
Topics: Adult; Delayed Diagnosis; Female; Glucagon; Glucagonoma; Humans; Necrolytic Migratory Erythema; Pancreatic Neoplasms; Paraneoplastic Endocrine Syndromes | 2016 |
Characterization of pancreatic glucagon-producing tumors and pituitary gland tumors in transgenic mice overexpressing MYCN in hGFAP-positive cells.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Gene Expression; Gene Expression Profiling; Glial Fibrillary Acidic Protein; Glucagon; Glucagonoma; Humans; Immunohistochemistry; Mice; Mice, Transgenic; N-Myc Proto-Oncogene Protein; Neuroendocrine Tumors; Pancreatic Neoplasms; Pituitary Neoplasms; Transcriptome | 2016 |
Glucagon and Amino Acids Are Linked in a Mutual Feedback Cycle: The Liver-α-Cell Axis.
Topics: Amino Acids; Animals; Feedback; Glucagon; Glucagon-Secreting Cells; Glucagonoma; Glucose; Humans; Liver; Mice; Mutation; Pancreatic Neoplasms; Receptors, Glucagon; Urea | 2017 |
Glucagonoma: anaesthetic management.
Topics: Anesthesia, General; Blood Glucose; Female; Glucagon; Glucagonoma; Humans; Middle Aged; Pancreatic Neoplasms | 2009 |
Glucagonoma diagnosed by arterial stimulation and venous sampling (ASVS).
Topics: Aged; Calcium; Female; Glucagon; Glucagonoma; Humans; Multiple Endocrine Neoplasia Type 1; Mutation; Pancreatic Neoplasms | 2009 |
Images in clinical medicine. Necrolytic migratory erythema.
Topics: Cheilitis; Diabetes Mellitus; Erythema; Female; Glossitis; Glucagon; Glucagonoma; Humans; Middle Aged; Pancreatic Neoplasms | 2010 |
Alpha cell-specific Men1 ablation triggers the transdifferentiation of glucagon-expressing cells and insulinoma development.
Topics: Age Factors; Aging; Animals; Biomarkers; Cell Fusion; Cell Lineage; Cell Proliferation; Cell Transdifferentiation; Cell Transformation, Neoplastic; Gene Deletion; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genotype; Glucagon; Glucagon-Secreting Cells; Glucagonoma; Insulin; Insulin-Secreting Cells; Insulinoma; Mice; Mice, Knockout; Pancreatic Neoplasms; Phenotype; Proto-Oncogene Proteins; Transcription Factors | 2010 |
Glucagonoma syndrome and necrolytic migratory erythema.
Topics: Aged; Biopsy; Erythema; Glucagon; Glucagonoma; Humans; Male; Necrosis; Pancreatectomy; Pancreatic Neoplasms; Skin; Tomography, X-Ray Computed | 2010 |
[Malignant glucagonoma: an uncommon cause of new onset diabetes].
Topics: Adult; Alopecia; Anemia; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Chromogranin A; Combined Modality Therapy; Diabetes Mellitus; Female; Glossitis; Glucagon; Glucagonoma; Humans; Hyperglycemia; Necrolytic Migratory Erythema; Octreotide; Pancreatectomy; Pancreatic Neoplasms; Weight Loss | 2011 |
Glucagon cell adenomatosis: a new entity associated with necrolytic migratory erythema and glucagonoma syndrome.
Topics: Adult; Biopsy, Needle; Disease Progression; Drug Therapy, Combination; Fatal Outcome; Glucagon; Glucagon-Secreting Cells; Glucagonoma; Humans; Immunohistochemistry; Male; Necrolytic Migratory Erythema; Pancreatic Neoplasms; Risk Assessment; Severity of Illness Index | 2011 |
A case of a giant glucagonoma with parathyroid hormone-related peptide secretion showing an inconsistent postsurgical endocrine status.
Topics: Bone Neoplasms; Female; Glucagon; Glucagonoma; Humans; Liver Neoplasms; Middle Aged; Pancreatic Neoplasms; Parathyroid Hormone-Related Protein; Postoperative Period | 2011 |
An unusual case of subclinical diffuse glucagonoma coexisting with two nodules in the pancreas: characteristic features on computed tomography.
Topics: Fluorodeoxyglucose F18; Glucagon; Glucagonoma; Humans; Male; Middle Aged; Pancreatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Asymptomatic insulinoma: a case report and autopsy series.
Topics: Autopsy; Calcium Gluconate; Diagnosis, Differential; Early Detection of Cancer; Female; Glucagon; Glucagonoma; Humans; Hypoglycemia; Insulin; Insulin Secretion; Insulinoma; Islets of Langerhans; Middle Aged; Pancreas; Pancreatic Neoplasms; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Migratory necrolytic erythema and glucagonoma.
Topics: Aged; Dermatitis; Erythema; Female; Glucagon; Glucagonoma; Humans; Pancreatic Neoplasms; Paraneoplastic Syndromes | 2003 |
Pancreatic vasopressin V1b receptors: characterization in In-R1-G9 cells and localization in human pancreas.
Topics: Animals; Binding, Competitive; Calcium; Cell Division; Cricetinae; Glucagon; Glucagonoma; Hormone Antagonists; Humans; Immunohistochemistry; Indoles; Islets of Langerhans; Pyrrolidines; Receptors, Vasopressin; RNA, Messenger; Tritium; Tumor Cells, Cultured; Vasoconstrictor Agents; Vasopressins | 2003 |
Amylin in pancreatic islets and pancreatic endocrine neoplasms.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amyloid; Biomarkers, Tumor; Female; Glucagon; Glucagonoma; Humans; Immunoenzyme Techniques; Insulin; Insulinoma; Islet Amyloid Polypeptide; Islets of Langerhans; Male; Middle Aged; Pancreatic Neoplasms; Pancreatic Polypeptide; Somatostatin | 2003 |
[Necrolytic migratory erythema revealing glucagonoma without diabetes].
Topics: Aged; Blood Glucose; Erythema; Follow-Up Studies; Glucagon; Glucagonoma; Humans; Insulin; Insulin Secretion; Male; Necrosis; Pancreatic Neoplasms; Skin; Syndrome; Time Factors | 2003 |
Migratory necrolytic dermatitis presenting after cephalosporin administration in a patient with a pancreatic head mass.
Topics: Aged; Amino Acids; Anti-Bacterial Agents; Cephalosporins; Dermatitis; Diagnostic Errors; Glucagon; Glucagonoma; Humans; Male; Pancreatic Neoplasms; Pancreaticoduodenectomy; Treatment Outcome | 2004 |
Glucagonoma and pseudoglucagonoma syndrome.
Topics: Aged; Diagnosis, Differential; Female; Glucagon; Glucagonoma; Humans; Male; Middle Aged; Pancreatic Neoplasms; Retrospective Studies; Treatment Outcome | 2004 |
Necrolytic migratory erythema: a cutaneous clue to glucagonoma syndrome.
Topics: Diagnosis, Differential; Exanthema; Glucagon; Glucagonoma; Humans; Leg; Male; Middle Aged; Pancreatectomy; Pancreatic Neoplasms; Splenectomy; Tomography, X-Ray Computed | 2004 |
Glucagon release is regulated by tyrosine phosphatase and PI3-kinase activity.
Topics: Androstadienes; Animals; Arginine; Cell Line, Tumor; Cricetinae; Enzyme Inhibitors; Glucagon; Glucagonoma; Hypoglycemic Agents; Immunoprecipitation; Insulin; Insulin Secretion; Male; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Tyrosine Phosphatases; Rats; Rats, Inbred Strains; Rats, Wistar; Signal Transduction; Vanadates; Wortmannin | 2004 |
Metastatic insulinoma and glucagonoma from the pancreas responsible for specific peritumoral patterns of hepatic steatosis secondary to local effects of insulin and glucagon on hepatocytes.
Topics: Adult; Fatty Liver; Female; Glucagon; Glucagonoma; Hepatocytes; Humans; Insulin; Insulin Secretion; Insulinoma; Liver; Liver Neoplasms; Pancreatic Neoplasms; Radiography | 2005 |
Metastatic glucagonoma: treatment with liver transplantation.
Topics: Antineoplastic Agents, Hormonal; Glucagon; Glucagonoma; Humans; Immunohistochemistry; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Octreotide; Pancreatectomy; Pancreatic Neoplasms; Radionuclide Imaging; Receptors, Somatostatin; Splenectomy | 2006 |
Malignant glucagonoma. New options of treatment.
Topics: Aged; Chromogranin A; Chromogranins; Female; Glucagon; Glucagonoma; Humans; Immunohistochemistry; Interferon-alpha; Neuroendocrine Tumors; Octreotide; Proglucagon; Time Factors; Tomography, X-Ray Computed | 2006 |
Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years.
Topics: Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Erythema; Female; Glucagon; Glucagonoma; Humans; Interferons; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Receptors, Somatostatin; Retrospective Studies; Sex Factors; Survival Analysis; Treatment Outcome | 2007 |
A case of glucagonoma at the uncinate process of the pancreas successfully treated by pancreaticoduodenectomy.
Topics: Aged; Glucagon; Glucagonoma; Humans; Male; Pancreatic Neoplasms; Pancreaticoduodenectomy; Tomography, X-Ray Computed | 2008 |
What is your diagnosis? Necrolytic migratory erythema associated with a glucagonoma.
Topics: Erythema; Female; Glucagon; Glucagonoma; Humans; Middle Aged; Pancreatic Neoplasms; Paraneoplastic Syndromes; Skin; Skin Diseases | 2008 |
Immunologic characterization of plasma glucagon components in a patient with malignant glucagonoma.
Topics: Adenoma, Islet Cell; Blood Glucose; Chromatography, Gel; Glucagon; Glucagonoma; Humans; Male; Middle Aged; Molecular Weight; Pancreatic Neoplasms; Radioimmunoassay; Streptozocin | 1984 |
Glucagonoma syndrome: in vitro evidence that glucagon increases epidermal arachidonic acid.
Topics: Adenoma, Islet Cell; Arachidonic Acids; Epidermis; Erythema; Facial Dermatoses; Female; Glucagon; Glucagonoma; Humans; In Vitro Techniques; Middle Aged; Pancreatic Neoplasms; Perineum; Syndrome; Thorax; Tongue Diseases | 1984 |
Cytoreduction surgery for metastatic glucagonoma. A clinicopathologic study with special reference to the utility of immunocytochemistry and ultrastructure in diagnosis.
Topics: Adenoma, Islet Cell; Glucagon; Glucagonoma; Humans; Immunoenzyme Techniques; Liver Neoplasms; Male; Microscopy, Electron; Middle Aged; Pancreatectomy; Pancreatic Neoplasms | 1984 |
[Necrolytic migratory erythema: glucagonoma syndrome. Clinical and histological aspects].
Topics: Adenoma, Islet Cell; Erythema; Female; Follow-Up Studies; Glucagon; Glucagonoma; Humans; Middle Aged; Necrosis; Pancreatic Neoplasms; Paraneoplastic Syndromes | 1984 |
[Pancreatic secreting glucagonoma: inhibitory effect of somatostatin-14 (author's transl)].
Topics: Adenoma, Islet Cell; Glucagon; Glucagonoma; Humans; Male; Middle Aged; Pancreatic Neoplasms; Somatostatin | 1981 |
Glucagon-secreting pancreatic islet cell carcinoma, containing insulin and somatostatin, with hypoglycemic attack.
Topics: Adenoma, Islet Cell; Female; Glucagon; Glucagonoma; Humans; Hypoglycemia; Insulin; Insulin Secretion; Middle Aged; Pancreatic Neoplasms; Somatostatin | 1982 |
The glucagonoma syndrome: stimulus-induced plasma responses of circulating glucagon components IRG9000 and IRG3500.
Topics: Adenoma, Islet Cell; Arginine; Calcitonin; Calcium; Chromatography, Gel; Fasting; Female; Glucagon; Glucagonoma; Humans; Middle Aged; Molecular Weight; Pancreatic Neoplasms; Radioimmunoassay; Somatostatin; Tolbutamide | 1984 |
Operative and chemotherapeutic management of malignant glucagon-producing tumors.
Topics: Adenoma, Islet Cell; Body Weight; Dacarbazine; Dermatitis; Diabetes Mellitus; Glucagon; Glucagonoma; Humans; Male; Middle Aged; Pancreatectomy; Pancreatic Neoplasms; Scotoma; Syndrome | 1981 |
[Necrolytic migratory erythema in glucagonoma syndrome (author's transl)].
Topics: Adenoma, Islet Cell; Erythema; Female; Glucagon; Glucagonoma; Humans; Middle Aged; Necrosis; Pancreatic Neoplasms | 1981 |
A case with glucagonoma syndrome--endocrine and metabolic studies.
Topics: Adenoma, Islet Cell; C-Peptide; Endocrine Glands; Female; Glucagon; Glucagonoma; Glucose Tolerance Test; Humans; Insulin; Liver Neoplasms; Middle Aged; Pancreatic Neoplasms; Tolbutamide | 1981 |
[A human pancreatic glucagonoma, ultrastructural, immunocytochemical and radioimmunological investigations (author's transl)].
Topics: Adenoma, Islet Cell; Fluorescent Antibody Technique; Glucagon; Glucagonoma; Humans; Male; Microscopy, Electron; Middle Aged; Pancreatic Neoplasms; Radioimmunoassay | 1981 |
The metabolic effects of chronic hyperglucagonaemia.
Topics: Adenoma, Islet Cell; Blood Glucose; Cyclic AMP; Glucagon; Glucagonoma; Glucose Tolerance Test; Humans; Insulin; Male; Metabolic Clearance Rate; Middle Aged; Pancreatic Neoplasms | 1981 |
A postmortem study of malignant glucagonoma with heart muscle hypertrophy, including chemical, histochemical, immunohistological and ultrastructural observations.
Topics: Adenoma, Islet Cell; Cardiomegaly; Female; Glucagon; Glucagonoma; Humans; Microscopy, Electron; Middle Aged; Myocardium; Necrosis; Pancreas; Pancreatic Neoplasms; Skin | 1981 |
Cutaneous and oral changes as the only manifestations of the glucagonoma syndrome.
Topics: Adenoma, Islet Cell; Adult; Anemia; Body Weight; Diagnosis, Differential; Erythema; Glossitis; Glucagon; Glucagonoma; Humans; Male; Pancreatic Neoplasms; Syndrome | 1982 |
[Glucagonoma syndrome in a multihormonal pancreatic tumor].
Topics: Adenoma, Islet Cell; Anemia; Body Weight; Dermatitis; Gastrins; Glucagon; Glucagonoma; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Pancreatic Neoplasms; Pancreatic Polypeptide; Secretin; Syndrome | 1982 |
[Glucagonoma and somatostatinoma].
Topics: Adenoma, Islet Cell; Aged; Female; Glucagon; Glucagonoma; Humans; Male; Middle Aged; Pancreatic Neoplasms; Somatostatinoma | 1982 |
[Glucagonoma with diabetic ketoacidosis; case report].
Topics: Adenoma, Islet Cell; Aged; Blood Glucose; C-Peptide; Diabetic Ketoacidosis; Female; Glucagon; Glucagonoma; Humans; Pancreatic Neoplasms | 1982 |
[A case of glucagonoma].
Topics: Adenoma, Islet Cell; Adult; Female; Glucagon; Glucagonoma; Humans; Pancreatic Neoplasms | 1982 |
Glucagonomas. Ultrastructure and immunocytochemistry.
Topics: Adenoma, Islet Cell; Aged; Diabetes Complications; Female; Glucagon; Glucagonoma; Histocytochemistry; Humans; Immunoenzyme Techniques; Male; Microscopy, Electron; Middle Aged; Pancreatic Neoplasms; Pancreatic Polypeptide | 1983 |
Molecular heterogeneity of glucagon in normal subjects and in patients with glucagon-producing tumours.
Topics: Adenoma, Islet Cell; Aged; Chemical Phenomena; Chemistry; Chromatography, Gel; Female; Glucagon; Glucagonoma; Humans; Kinetics; Male; Middle Aged; Molecular Weight; Pancreatic Neoplasms; Radioimmunoassay | 1983 |
Disappearance of glucagonoma rash after surgical resection, but not during dietary normalization of serum amino acids.
Topics: Adenoma, Islet Cell; Amino Acids; Blood Glucose; Dermatitis; Glucagon; Glucagonoma; Humans; Insulin; Male; Middle Aged; Nitrogen; Pancreatic Neoplasms | 1984 |
Glucagonoma occurring as a large cystic abdominal mass.
Topics: Abdominal Neoplasms; Adenoma, Islet Cell; Aged; Cysts; Diagnosis, Differential; Female; Glucagon; Glucagonoma; Humans; Pancreatic Neoplasms | 1984 |
Secretory granules in benign and malignant glucagonomas of the pancreas.
Topics: Adenoma, Islet Cell; Adult; C-Peptide; Cytoplasmic Granules; Glucagon; Glucagonoma; Humans; Insulinoma; Male; Neoplasm Metastasis; Neoplasms, Multiple Primary; Pancreatic Neoplasms; Radioimmunoassay | 1984 |
Glucagonoma syndrome demonstrating giant duodenal villi.
Topics: Adenoma, Islet Cell; Adult; Chromatography, Affinity; Chromatography, Gel; Duodenum; Glucagon; Glucagonoma; Humans; Intestinal Mucosa; Male; Pancreatic Neoplasms; Skin Diseases, Vesiculobullous; Syndrome | 1984 |
Increased specificity of plasma glucagon radioimmunoassay by use of acetone extraction.
Topics: Acetone; Acute Kidney Injury; Ethanol; Glucagon; Glucagonoma; Humans; Molecular Weight; Peptide Fragments; Proglucagon; Protein Precursors; Radioimmunoassay | 1983 |
Molecular and functional characterization of insulin receptors present on hamster glucagonoma cells.
Topics: Animals; Blotting, Northern; Chloramphenicol O-Acetyltransferase; Cricetinae; Data Interpretation, Statistical; Gene Expression Regulation; Glucagon; Glucagonoma; Insulin; Islets of Langerhans; Ligands; Proglucagon; Protein Precursors; Receptor, Insulin; RNA; Transfection; Tumor Cells, Cultured | 1994 |
Transplantable glucagonomas derived from pluripotent rat islet tumor tissue cause severe anorexia and adipsia.
Topics: Animals; Anorexia; Body Weight; Drinking; Eating; Glucagon; Glucagonoma; Islets of Langerhans; Mice; Mice, Inbred C57BL; Mice, Obese; Neoplasm Transplantation; Pancreatic Neoplasms; Peptide Fragments; Phenotype; Proglucagon; Protein Precursors; Rats; RNA, Messenger; Stem Cells; Tumor Cells, Cultured | 1995 |
Clinico-pathological correlation of glucagon-positive pancreatic endocrine tumours: a presentation of five cases.
Topics: Adult; Endocrine Gland Neoplasms; Female; Glucagon; Glucagonoma; Humans; Male; Middle Aged; Pancreatic Neoplasms | 1995 |
The glucagon gene is transcribed in beta-like pancreatic cells.
Topics: Animals; Base Sequence; Binding Sites; Cell Line, Transformed; Glucagon; Glucagonoma; Humans; Insulinoma; Islets of Langerhans; Molecular Sequence Data; Polymerase Chain Reaction; Rats; Sequence Alignment; Transcription, Genetic | 1995 |
[The functionally inactive endocrine pancreas tumor].
Topics: Adult; Biomarkers, Tumor; Female; Glucagon; Glucagonoma; Humans; Hypercalcemia; Neoplasms, Multiple Primary; Pancreas; Pancreatic Neoplasms; Paraneoplastic Endocrine Syndromes | 1994 |
Glucagon-like peptide-1 (GLP-1) molecular forms in human pancreatic endocrine tumors resemble those in intestine rather than pancreas.
Topics: Chromatography, High Pressure Liquid; Glucagon; Glucagon-Like Peptide 1; Glucagonoma; Humans; Insulinoma; Pancreatic Neoplasms; Peptide Fragments; Protein Precursors; Radioimmunoassay; Reference Values | 1994 |
Functional characterization of somatostatin receptors expressed on hamster glucagonoma cells.
Topics: Adenylyl Cyclases; Animals; Cricetinae; Cross-Linking Reagents; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Gene Expression; Glucagon; Glucagonoma; Pancreatic Neoplasms; Proglucagon; Protein Precursors; Receptors, Somatostatin; Somatostatin; Tumor Cells, Cultured | 1995 |
Acetylcholine regulates glucagon secretion from human glucagonoma cells.
Topics: Carbachol; Glucagon; Glucagonoma; Humans; Male; Middle Aged; Pancreatic Neoplasms; Pancreatic Polypeptide; Tumor Cells, Cultured; Vasoactive Intestinal Peptide | 1994 |
An immunohistochemical study of glucagonoma conducted on the metastatic lymph nodes from a patient with recurrent metastatic glucagonoma: report of a case.
Topics: Aged; Female; Glucagon; Glucagonoma; Humans; Immunohistochemistry; Lymphatic Metastasis; Microscopy, Electron; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Protein Kinase C | 1994 |
Expression of chromogranin A and B and secretoneurin immunoreactivity in neoplastic and nonneoplastic pancreatic alpha cells.
Topics: Antibodies, Monoclonal; Chromogranin A; Chromogranins; Glucagon; Glucagonoma; Humans; Immunoenzyme Techniques; Islets of Langerhans; Neuroendocrine Tumors; Neuropeptides; Pancreatic Neoplasms; Paraneoplastic Syndromes; Secretogranin II | 1994 |
Ras antagonizes cAMP stimulated glucagon gene transcription in pancreatic islet cell lines.
Topics: Adenoma, Islet Cell; Animals; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Genes, Dominant; Genes, ras; Glucagon; Glucagonoma; Insulinoma; Mutation; Promoter Regions, Genetic; Protein Kinase C; ras Proteins; Rats; Recombinant Fusion Proteins; RNA, Messenger; Signal Transduction; Transcription, Genetic; Transfection; Tumor Cells, Cultured | 1994 |
The long-acting somatostatin analogue octreotide alleviates symptoms by reducing posttranslational conversion of prepro-glucagon to glucagon in a patient with malignant glucagonoma, but does not prevent tumor growth.
Topics: Cell Division; Chromatography, Gel; Delayed-Action Preparations; Female; Glucagon; Glucagonoma; Humans; Middle Aged; Octreotide; Pancreatic Neoplasms; Proglucagon; Protein Precursors; Protein Processing, Post-Translational; Remission Induction | 1994 |
Sulfonylurea-binding sites and ATP-sensitive K+ channels in alpha-TC glucagonoma and beta-TC insulinoma cells.
Topics: Adenosine Triphosphate; Animals; Binding Sites; Binding, Competitive; Diazoxide; Glucagon; Glucagonoma; Glyburide; Insulinoma; Kinetics; Membrane Potentials; Mice; Pancreatic Neoplasms; Potassium Channels; Tolbutamide; Tritium; Tumor Cells, Cultured | 1993 |
Abnormal facilitative glucose transporter gene expression in human islet cell tumors.
Topics: Base Sequence; Female; Gastrinoma; Gastrins; Gene Expression; Gene Expression Regulation, Neoplastic; Glucagon; Glucagonoma; Humans; Insulin; Insulinoma; Male; Middle Aged; Molecular Sequence Data; Monosaccharide Transport Proteins; Oligodeoxyribonucleotides; Pancreatic Neoplasms; Polymerase Chain Reaction; RNA, Messenger | 1993 |
A 73-year-old man with hyperglycemia, skin rashes, anemia and weight loss.
Topics: Aged; Anemia; Diagnosis, Differential; Erythema; Glucagon; Glucagonoma; Humans; Hyperglycemia; Male; Pancreatic Neoplasms; Tomography, X-Ray Computed; Weight Loss | 1996 |
The glucose sensor protein glucokinase is expressed in glucagon-producing alpha-cells.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Base Sequence; Brain; Cells, Cultured; DNA Primers; DNA, Complementary; Glucagon; Glucagonoma; Glucokinase; Glucose; Glucose Transporter Type 2; Glutamine; Homeostasis; Insulin; Islets of Langerhans; Liver; Male; Molecular Sequence Data; Monosaccharide Transport Proteins; Pancreatic Neoplasms; Polymerase Chain Reaction; Rats; Rats, Wistar; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured | 1996 |
Induction of intestinal epithelial proliferation by glucagon-like peptide 2.
Topics: Animals; Cell Division; Glicentin; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glucagon-Like Peptides; Glucagonoma; Ileum; Immunohistochemistry; Intestinal Mucosa; Jejunum; Kinetics; Mice; Mice, Nude; Organ Size; Pancreatic Hormones; Pancreatic Neoplasms; Peptide Fragments; Peptides; Proglucagon; Proliferating Cell Nuclear Antigen; Protein Precursors; Rats; Transplantation, Heterologous | 1996 |
Induction of insulin and islet amyloid polypeptide production in pancreatic islet glucagonoma cells by insulin promoter factor 1.
Topics: Amyloid; Animals; Anorexia; Blood Glucose; DNA-Binding Proteins; Gene Expression Regulation; Glucagon; Glucagonoma; Homeodomain Proteins; Hypoglycemia; Insulin; Islet Amyloid Polypeptide; Islets of Langerhans; LIM-Homeodomain Proteins; Neoplasms, Experimental; Nerve Tissue Proteins; Phenotype; Rats; Trans-Activators; Transcription Factors; Transcription, Genetic; Transfection; Tumor Cells, Cultured | 1996 |
Clinical spectrum of hyperglucagonemia associated with malignant neuroendocrine tumors.
Topics: Adult; Aged; Blood Glucose; Carcinoid Tumor; Diabetes Mellitus; Female; Glucagon; Glucagonoma; Hormones; Humans; Insulinoma; Male; Middle Aged; Multiple Endocrine Neoplasia; Neuroendocrine Tumors; Retrospective Studies; Zollinger-Ellison Syndrome | 1996 |
[Paraneoplastic spastic tetraparesis in glucagonoma syndrome. Successful therapy with octreotide, dacarbazine and interferon-alpha].
Topics: Adult; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacarbazine; Diagnostic Imaging; Glucagon; Glucagonoma; Humans; Interferon-alpha; Liver Neoplasms; Male; Octreotide; Pancreatectomy; Pancreatic Neoplasms; Paraneoplastic Syndromes; Quadriplegia | 1996 |
FA1 immunoreactivity in endocrine tumours and during development of the human fetal pancreas; negative correlation with glucagon expression.
Topics: Antibodies, Monoclonal; Endocrine Gland Neoplasms; Epidermal Growth Factor; Fetus; Fluorescent Antibody Technique; Glucagon; Glucagonoma; Glycoproteins; Humans; Insulin; Insulinoma; Neuroendocrine Tumors; Pancreas; Pheochromocytoma; Somatostatin; Tumor Cells, Cultured | 1996 |
Cystic glucagonoma with loss of heterozygosity on chromosome 11 in multiple endocrine neoplasia type 1.
Topics: Arginine; Chromosomes, Human, Pair 11; Glucagon; Glucagonoma; Glucose Tolerance Test; Homozygote; Humans; Male; Middle Aged; Multiple Endocrine Neoplasia Type 1; Pancreatic Neoplasms; Ultrasonography | 1997 |
In vivo and in vitro effects of somatostatin and insulin on glucagon release in a human glucagonoma.
Topics: Chromogranin A; Chromogranins; Depression, Chemical; Glucagon; Glucagonoma; Glucose; Hormones; Humans; Immunohistochemistry; Insulin; Male; Middle Aged; Octreotide; Pancreatic Neoplasms; Pancreatic Polypeptide; Tumor Cells, Cultured | 1997 |
Transplantable rat glucagonomas cause acute onset of severe anorexia and adipsia despite highly elevated NPY mRNA levels in the hypothalamic arcuate nucleus.
Topics: Animals; Anorexia; Arcuate Nucleus of Hypothalamus; Drinking; Female; Glucagon; Glucagon-Like Peptide 1; Glucagonoma; Male; Neoplasm Transplantation; Neuropeptide Y; Pancreatic Neoplasms; Peptide Fragments; Protein Precursors; Rats; RNA, Messenger; Weight Loss | 1998 |
Contribution of a PS1-like element to the tissue- and cell-specific expression of the human GLP-1 receptor gene.
Topics: Animals; Base Sequence; Cell Line; Cell Nucleus; Cloning, Molecular; Cricetinae; Enhancer Elements, Genetic; Gene Expression Regulation; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucagonoma; Humans; Insulinoma; Islets of Langerhans; Molecular Sequence Data; Mutagenesis, Site-Directed; Organ Specificity; Pancreatic Neoplasms; Peptide Fragments; Promoter Regions, Genetic; Protein Precursors; Receptors, Glucagon; Recombinant Proteins; Sequence Deletion; Sequence Homology, Nucleic Acid; Simian virus 40; Transfection; Tumor Cells, Cultured | 1998 |
Effects of arginine vasopressin and oxytocin on glucagon release from clonal alpha-cell line In-R1-G9: involvement of V1b receptors.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Cricetinae; Dose-Response Relationship, Drug; Glucagon; Glucagonoma; Hormone Antagonists; Islets of Langerhans; Oxytocin; Pancreatic Neoplasms; Peptides, Cyclic; Receptors, Oxytocin; Receptors, Vasopressin; Renal Agents; Tumor Cells, Cultured | 1998 |
A nutrient-regulated cytosolic calcium oscillator in endocrine pancreatic glucagon-secreting cells.
Topics: Alanine; Animals; Calcium; Carbachol; Cricetinae; Cytosol; Energy Metabolism; Glucagon; Glucagonoma; Glucose; Glutamine; Homeostasis; Islets of Langerhans; Membrane Potentials; Muscarinic Agonists; Pancreatic Neoplasms; Periodicity; Sodium-Potassium-Exchanging ATPase; Tumor Cells, Cultured | 1999 |
[Necrolytic migratory erythema].
Topics: Adrenal Cortex Hormones; Amino Acids; Diagnosis, Differential; Erythema; Fatty Acids, Essential; Glucagon; Glucagonoma; Humans; Necrosis; Pancreatic Neoplasms; Paraneoplastic Syndromes; Zinc | 1998 |
Glucagonoma syndrome: survival 24 years following diagnosis.
Topics: Aged; Disease-Free Survival; Female; Follow-Up Studies; Glucagon; Glucagonoma; Humans; Pancreatectomy; Pancreatic Neoplasms; Syndrome; Time Factors; Treatment Outcome | 1999 |
Protein metabolism in glucagonoma.
Topics: Adult; Amino Acids; Blood Glucose; C-Peptide; Deuterium; Female; Glucagon; Glucagonoma; Humans; Infusions, Intravenous; Insulin; Leucine; Male; Middle Aged; Pancreatic Neoplasms; Phenylalanine; Protein Biosynthesis; Proteins; Reference Values; Tyrosine | 1999 |
[Glucagon-secreting malignant neuroendocrine tumor of the pancreas].
Topics: Adrenal Gland Neoplasms; Aged; Diabetes Mellitus; Diagnosis, Differential; Glucagon; Glucagonoma; Humans; Liver Neoplasms; Male; Multiple Endocrine Neoplasia; Pancreatic Neoplasms | 2000 |
Glucagon-producing neuroendocrine tumour associated with hypoaminoacidaemia and skin lesions.
Topics: Adenoma, Islet Cell; Amino Acids; Animals; Dog Diseases; Dogs; Female; Glucagon; Glucagonoma; Immunohistochemistry; Necrosis; Neuroendocrine Tumors; Somatostatin | 2000 |
Immunohistochemical assessment of an asymptomatic glucagonoma in a patient with hypergastrinemia and marked antral angiodysplasia.
Topics: Diagnosis, Differential; Gastric Antral Vascular Ectasia; Gastrins; Glucagon; Glucagonoma; Humans; Immunohistochemistry; Male; Middle Aged; Multiple Endocrine Neoplasia Type 1; Pancreatic Neoplasms; Pyloric Antrum | 2001 |
Mechanisms of bradykinin-induced glucagon release in clonal alpha-cells In-R1-G9: involvement of Ca(2+)-dependent and -independent pathways.
Topics: Animals; Bradykinin; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Signaling; Chelating Agents; Clone Cells; Cricetinae; Egtazic Acid; Endoplasmic Reticulum; Enzyme Inhibitors; Estrenes; Glucagon; Glucagonoma; GTP-Binding Proteins; Heparin; Imidazoles; Inositol 1,4,5-Trisphosphate Receptors; Mesocricetus; Microinjections; Pancreatic Neoplasms; Pertussis Toxin; Phospholipase D; Pyrrolidinones; Receptor, Bradykinin B2; Receptors, Bradykinin; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Thapsigargin; Tumor Cells, Cultured; Type C Phospholipases | 2002 |
A Chinese woman with glucagonoma syndrome.
Topics: Adenoma, Islet Cell; Aged; Diabetes Mellitus, Type 1; Female; Glucagon; Glucagonoma; Humans; Pancreatic Neoplasms; Syndrome | 1992 |
In vivo assessment of the metabolic alterations in glucagonoma syndrome.
Topics: Adult; Amino Acids; Blood Glucose; Energy Metabolism; Fatty Acids, Nonesterified; Female; Glucagon; Glucagonoma; Humans; Hydroxybutyrates; Male; Middle Aged; Oxygen Consumption; Pancreatic Neoplasms; Reference Values; Syndrome | 1992 |
Glucagonomas of transgenic mice express a wide range of general neuroendocrine markers and bioactive peptides.
Topics: Animals; Antigens, Polyomavirus Transforming; Biomarkers; Glucagon; Glucagon-Like Peptide 1; Glucagonoma; Immunohistochemistry; Insulin; Mice; Mice, Transgenic; Pancreatic Neoplasms; Pancreatic Polypeptide; Peptide Fragments; Proglucagon; Protein Precursors; Radioimmunoassay; Somatostatin | 1991 |
Morphological changes in the human endocrine pancreas induced by chronic excess of endogenous glucagon.
Topics: Adolescent; Adult; Female; Glucagon; Glucagonoma; Humans; Immunoenzyme Techniques; Insulin; Islets of Langerhans; Middle Aged; Pancreas; Pancreatic Neoplasms; Pancreatic Polypeptide; Somatostatin | 1991 |
Treatment of necrolytic migratory erythema in glucagonoma syndrome.
Topics: Adult; Amino Acids; Erythema; Female; Glucagon; Glucagonoma; Humans; Infusions, Intravenous; Leg Dermatoses; Necrosis; Recurrence; Syndrome | 1991 |
[Glucagonoma and somatostatinoma].
Topics: Dacarbazine; Female; Glucagon; Glucagonoma; Glucose; Humans; Liver; Middle Aged; Octreotide; Pancreatic Neoplasms; Somatostatinoma; Streptozocin | 1991 |
Islet amyloid polypeptide and insulin expression are controlled differently in primary and transformed islet cells.
Topics: Amyloid; Animals; Animals, Newborn; Cell Line; Cell Line, Transformed; Gene Expression Regulation; Glucagon; Glucagonoma; Growth Hormone; Humans; Immunohistochemistry; Insulin; Insulinoma; Islet Amyloid Polypeptide; Islets of Langerhans; Mice; Pancreatic Neoplasms; Rats; RNA, Messenger; Simian virus 40; Transfection | 1991 |
[61-year-old patient with diabetes mellitus, weight loss, nausea and vomiting after resection of a pancreatic tumor].
Topics: Biopsy, Needle; Diabetes Mellitus; Female; Glucagon; Glucagonoma; Humans; Immunohistochemistry; Liver; Liver Neoplasms; Middle Aged; Pancreatectomy; Pancreatic Neoplasms; Postoperative Complications | 1991 |
Presence of glucagon-containing peptides in a human pancreatic glucagonoma and its liver metastasis.
Topics: Chromatography, High Pressure Liquid; Glucagon; Glucagonoma; Humans; Liver Neoplasms; Pancreatic Neoplasms; Radioimmunoassay | 1991 |
Reversal of a neurologic paraneoplastic syndrome with octreotide (Sandostatin) in a patient with glucagonoma.
Topics: Aged; Evoked Potentials, Visual; Female; Glucagon; Glucagonoma; Humans; Octreotide; Optic Atrophy; Pancreatic Neoplasms; Paraneoplastic Syndromes; Visual Acuity | 1991 |
Molecular and cellular analysis of a neoplastic pancreatic A cell tumor.
Topics: Adenoma, Islet Cell; Blotting, Northern; Chromatography, High Pressure Liquid; Culture Techniques; Cytoplasm; Glicentin; Glucagon; Glucagon-Like Peptides; Glucagonoma; Humans; Immunohistochemistry; Insulin; Microscopy, Electron; Oxyntomodulin; Pancreatic Neoplasms; Peptide Fragments; Proglucagon; Protein Precursors; RNA, Neoplasm; Somatostatin | 1990 |
[Role of glucagon in carbohydrate metabolism system].
Topics: Amino Acids; Animals; Carbohydrate Metabolism; Glucagon; Glucagonoma; Glucose; Humans; Insulin; Islets of Langerhans; Proglucagon; Protein Precursors; Receptors, Gastrointestinal Hormone; Receptors, Glucagon; Second Messenger Systems; Somatostatin; Vasoactive Intestinal Peptide | 1990 |
Necrolytic migratory erythema: dyskeratotic dermatitis, a clue to early diagnosis.
Topics: Dermatitis; Diagnosis, Differential; Erythema; Female; Glucagon; Glucagonoma; Humans; Keratinocytes; Middle Aged; Pancreatic Neoplasms | 1991 |
Proglucagon processing similar to normal islets in pancreatic alpha-like cell line derived from transgenic mouse tumor.
Topics: Adenoma, Islet Cell; Animals; Cell Line; Chromatography, Gel; Chromatography, High Pressure Liquid; Glucagon; Glucagonoma; Insulin; Islets of Langerhans; Mice; Mice, Transgenic; Pancreatic Neoplasms; Proglucagon; Protein Precursors; Protein Processing, Post-Translational; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured | 1990 |
Somatostatin analogue and tissue cultures in the study of a human malignant glucagonoma.
Topics: Adenoma, Islet Cell; Animals; Chromatography, Gel; Female; Glucagon; Glucagonoma; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Transplantation; Octreotide; Pancreatic Neoplasms; Radioimmunoassay; Rats; Rats, Inbred Strains; Tumor Cells, Cultured | 1990 |
Somatostatin analogue in treatment of coexisting glucagonoma and pancreatic pseudocyst: dissociation of responses.
Topics: Adenoma, Islet Cell; Arginine; Blood Glucose; C-Peptide; Eosinophilia; Follow-Up Studies; Glucagon; Glucagonoma; Humans; Male; Middle Aged; Octreotide; Pancreatic Cyst; Pancreatic Neoplasms; Pancreatic Pseudocyst | 1990 |
[Plasma pancreatic glucagon assay and the clinical significance].
Topics: Arginine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glucagon; Glucagonoma; Glucose Tolerance Test; Humans; Insulin; Pancreatic Neoplasms; Radioimmunoassay; Specimen Handling | 1990 |
Glucagonoma syndrome is an underdiagnosed clinical entity.
Topics: Female; Glucagon; Glucagonoma; Humans; Male; Middle Aged; Nebraska; Pancreatic Neoplasms; Skin Diseases; Syndrome; Time Factors | 1990 |
[Inhibition of pancreatic apudoma-dependent hypersecretion of gastrin, glucagon and serotonin using somatostatin-14].
Topics: Adult; Carcinoid Tumor; Female; Gastrins; Glucagon; Glucagonoma; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Pancreatic Neoplasms; Serotonin; Somatostatin; Zollinger-Ellison Syndrome | 1987 |
A malignant tumor of the pancreas producing glucagonoma syndrome: coexistence of glucagon and pancreatic polypeptide (PP) in the tumor cells.
Topics: Adenoma, Islet Cell; Female; Glucagon; Glucagonoma; Humans; Microscopy, Electron; Middle Aged; Pancreatic Neoplasms; Pancreatic Polypeptide | 1989 |
[Metastatic glucagonoma. A case report].
Topics: Adenoma, Islet Cell; Follow-Up Studies; Glucagon; Glucagonoma; Humans; Male; Middle Aged; Pancreatic Neoplasms | 1989 |
Glucagon synthesis with mRNA preparation of a glucagon-producing tumor (IT-1).
Topics: Adenoma, Islet Cell; Animals; Chromatography, Gel; Cricetinae; Glucagon; Glucagonoma; In Vitro Techniques; Pancreatic Neoplasms; Precipitin Tests; RNA, Messenger | 1989 |
[Pancreatic glucagonoma. Apropos of a case].
Topics: Adenoma, Islet Cell; Adult; Glucagon; Glucagonoma; Humans; Liver Neoplasms; Male; Pancreatectomy; Pancreatic Neoplasms | 1987 |
[Glucagonoma syndrome with normal blood glucagon ].
Topics: Adenoma, Islet Cell; Adult; Female; Glucagon; Glucagonoma; Humans; Pancreatic Neoplasms; Skin Diseases; Zinc | 1987 |
Metastatic islet cell tumour with clinical manifestations of insulin and glucagon excess: successful treatment by hepatic artery embolization and chemotherapy.
Topics: Adenoma, Islet Cell; Combined Modality Therapy; Embolization, Therapeutic; Female; Fluorouracil; Glucagon; Glucagonoma; Hepatic Artery; Humans; Insulin; Insulin Secretion; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Streptozocin | 1988 |
Glucagonoma syndrome.
Topics: Adenoma, Islet Cell; Arginine; Diagnostic Errors; Glucagon; Glucagonoma; Humans; Lymphatic Metastasis; Male; Middle Aged; Pancreatic Neoplasms; Skin Diseases; Syndrome | 1988 |
Symptomatic secondary hormone syndromes in patients with established malignant pancreatic endocrine tumors.
Topics: Adenoma, Islet Cell; Adult; Aged; Gastrins; Gastrointestinal Hemorrhage; Glucagon; Glucagonoma; Hormones; Humans; Insulinoma; Middle Aged; Pancreatic Neoplasms; Time Factors; Vasoactive Intestinal Peptide; Vipoma; Zollinger-Ellison Syndrome | 1988 |
[Iatrogenic glucagonoma syndrome?].
Topics: Adenoma, Islet Cell; Amino Acids; Female; Glucagon; Glucagonoma; Humans; Hypoglycemia; Iatrogenic Disease; Insulinoma; Middle Aged; Pancreatic Neoplasms; Skin Diseases; Syndrome | 1988 |
Multiple hormone secretion by a human pancreatic glucagonoma in culture.
Topics: Adenoma, Islet Cell; Cells, Cultured; Female; Fluorescent Antibody Technique; Gastrins; Glucagon; Glucagonoma; Humans; Immunoenzyme Techniques; Insulin; Insulin Secretion; Kinetics; Middle Aged; Neurotensin; Pancreatic Hormones; Pancreatic Neoplasms; Pancreatic Polypeptide; Somatostatin; Vasoactive Intestinal Peptide | 1985 |
A functional study of a case of glucagonoma exhibiting typical glucagonoma syndrome.
Topics: Adenoma, Islet Cell; Arginine; Blood Glucose; Chromatography, Gel; Dacarbazine; Endocrine Glands; Gastric Inhibitory Polypeptide; Glucagon; Glucagonoma; Glucose Tolerance Test; Humans; Insulin; Male; Middle Aged; Pancreatic Neoplasms; Secretin; Somatostatin | 1986 |
Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995.
Topics: Adenoma, Islet Cell; Alanine; Body Weight; Dermatitis; Glucagon; Glucagonoma; Humans; Male; Middle Aged; Octreotide; Pancreatic Neoplasms; Somatostatin | 1986 |
[The glucagonoma syndrome. Review of the literature. Apropos of a case].
Topics: Adenoma, Islet Cell; Female; Glucagon; Glucagonoma; Humans; Hypokalemia; Liver Neoplasms; Middle Aged; Multiple Endocrine Neoplasia; Pancreatic Neoplasms; Renin; Syndrome | 1986 |
Use of a somatostatin analog (SMS 201-995) in the glucagonoma syndrome.
Topics: Adenoma, Islet Cell; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Diabetes Mellitus; Drug Evaluation; Erythema; Female; Fluorouracil; Glucagon; Glucagonoma; Humans; Liver Neoplasms; Male; Middle Aged; Octreotide; Pancreatic Neoplasms; Somatostatin; Streptozocin; Syndrome | 1986 |
Somatostatin analog-induced remission of necrolytic migratory erythema without changes in plasma glucagon concentration.
Topics: Adult; Antineoplastic Agents; Erythema; Female; Glucagon; Glucagonoma; Humans; Octreotide; Pancreatic Neoplasms; Somatostatin | 1986 |
Expression of peptide hormone genes in human islet cell tumors.
Topics: Adenoma, Islet Cell; Animals; Blotting, Northern; Genes; Glucagon; Glucagonoma; Humans; Insulin; Insulinoma; Pancreatic Neoplasms; Pancreatic Polypeptide; Rats; RNA, Messenger; Somatostatin | 1988 |
[An autopsy case of glucagonoma associated with production of several hormones].
Topics: Adenoma, Islet Cell; Adult; Calcitonin; Female; Glucagon; Glucagonoma; Humans; Hydrocortisone; Pancreatic Neoplasms; Somatostatin | 1988 |
Anaesthetic management of glucagonoma.
Topics: Adenoma, Islet Cell; Adult; Anesthesia, General; Blood Glucose; Female; Glucagon; Glucagonoma; Humans; Intraoperative Period; Pancreatic Neoplasms; Pancreatic Polypeptide; Postoperative Period | 1985 |
Papulosquamous eruption with weight loss: Necrolytic migratory erythema (glucagonoma syndrome).
Topics: Adenoma, Islet Cell; Adult; Amino Acids; Body Weight; Erythema; Glucagon; Glucagonoma; Humans; Male; Pancreatic Neoplasms; Syndrome | 1985 |
Differences in molecular heterogeneity of glucagon-like immunoreactivity in plasma and liver metastases of a patient with alpha-cell tumor.
Topics: Adenoma, Islet Cell; Adult; Chromatography, Gel; Female; Glucagon; Glucagonoma; Humans; Liver Neoplasms; Molecular Conformation; Pancreatic Neoplasms; Radioimmunoassay | 1985 |
[A glucagon-secreting alpha-cell carcinoma of the pancreas].
Topics: Adenoma, Islet Cell; Adult; Glucagon; Glucagonoma; Humans; Male; Pancreatic Neoplasms | 1985 |
Secretory response and immunochemical heterogeneity of glucagon in plasma and tumor extracts of a patient with glucagonoma.
Topics: Adenoma, Islet Cell; Adult; Blood Glucose; Chromatography, Gel; Glucagon; Glucagonoma; Humans; Immunochemistry; Insulin; Liver Neoplasms; Male; Pancreatic Neoplasms; Tissue Extracts | 1986 |
Response of glucagonoma syndrome to lomustine.
Topics: Adenoma, Islet Cell; Glucagon; Glucagonoma; Humans; Lomustine; Male; Pancreatic Neoplasms | 1986 |
Immunocytochemical characterization of 10 pancreatic tumours, associated with the glucagonoma syndrome, using antibodies to separate regions of the pro-glucagon molecule and other neuroendocrine markers.
Topics: Adenoma, Islet Cell; Adult; Aged; Chromogranins; Cytoplasmic Granules; Female; Glucagon; Glucagonoma; Histocytochemistry; Humans; Immune Sera; Immunoenzyme Techniques; Immunosorbent Techniques; Male; Microscopy, Electron; Middle Aged; Pancreatic Neoplasms; Pancreatic Polypeptide; Peptide Fragments; Phosphopyruvate Hydratase; Proglucagon; Protein Precursors | 1986 |
[Diagnostic imaging of glucagonoma and transcatheter arterial embolization in hepatic metastases--report of a case].
Topics: Adenoma, Islet Cell; Embolization, Therapeutic; Female; Glucagon; Glucagonoma; Hepatic Artery; Humans; Liver Neoplasms; Middle Aged; Pancreatic Neoplasms; Radiography | 1986 |
Histologic variation in the skin lesions of the glucagonoma syndrome.
Topics: Adenoma, Islet Cell; Female; Glucagon; Glucagonoma; Humans; Hyperplasia; Male; Middle Aged; Necrosis; Pancreas; Pancreatic Neoplasms; Skin; Skin Diseases; Syndrome | 1986 |
[A case report of malignant glucagonoma with a profile of immunoreactive glucagon before and after the operation].
Topics: Adenoma, Islet Cell; Glucagon; Glucagonoma; Humans; Male; Middle Aged; Pancreatic Neoplasms; Postoperative Period | 1986 |
[Clinical observation of 3 patients with glucagon-secreting pancreatic tumors].
Topics: Adenoma, Islet Cell; Adult; Female; Glucagon; Glucagonoma; Humans; Middle Aged; Pancreatic Neoplasms | 1986 |
A glucagon-secreting pancreatic alpha islet cell tumor presenting as spinal cord compression.
Topics: Adenoma, Islet Cell; Adult; Combined Modality Therapy; Glucagon; Glucagonoma; Humans; Lumbar Vertebrae; Male; Pancreatic Neoplasms; Spinal Cord Compression; Spinal Neoplasms; Thoracic Vertebrae | 1987 |
Angioplastic necrolytic migratory erythema. Unique association of necrolytic migratory erythema, extensive angioplasia, and high molecular weight glucagon-like polypeptide.
Topics: Adult; Autoradiography; Biopsy; Diabetes Complications; Erythema; Glucagon-Like Peptides; Glucagonoma; Humans; Male; Pancreatic Neoplasms; Peptides; Skin; Thymidine; Tritium | 1982 |